第三季度财务报表是否经审计 □是 √否 证券代码：601881 证券简称：中国银河 中国银河证券股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 公司负责人王晟、主管会计工作负责人薛军及会计机构负责人（会计主管人员）王淡森保证季度 报告中财务信息的真实、准确、完整。 1 中国银河证券股份有限公司 2025 年第三季度报告 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减变动 幅度(%) | | --- | --- | --- | --- | --- | | | | 调整前 | 调整后 | 调整后 | | 总资产 | 861,092,526,709.18 | 737,470,691,457.89 | 737,470,691,457.89 | 16.76 | | 归属于上市公司股 东的所有者权益 | 152,39 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥105,456,600.44, a decrease of 14.03% compared to the same period last year[5] - The net profit attributable to shareholders was -¥125,378.06, representing a decline of 100.93% year-on-year[5] - Basic earnings per share were -¥0.0009, a decrease of 100.92% compared to the same period last year[5] - Operating profit decreased to ¥41,693,959.38, down 25.4% from ¥55,873,604.57 year-over-year[20] - Net profit attributable to shareholders of the parent company was ¥36,673,596.51, a decline of 24.7% from ¥48,712,473.46 in the previous year[20] - Other comprehensive income after tax increased to ¥1,888,525.74, compared to ¥1,233,422.39 in the previous year, indicating improved financial performance in this area[20] Cash Flow - The net cash flow from operating activities was ¥9,166,362.02, down 66.30% from the previous year[5] - Operating cash flow for the current period is ¥9,166,362.02, a decrease of 66.3% compared to ¥27,203,657.73 in the previous period[22] - Net cash flow from financing activities decreased by 72.60% to -¥17,368,781.70, reflecting reduced cash related to financing activities[10] - Cash flow from financing activities shows a net outflow of -¥17,368,781.70, compared to -¥63,400,976.01 in the previous period, indicating an improvement[23] - The ending balance of cash and cash equivalents is ¥98,166,085.68, down from ¥118,081,846.36 in the previous period[23] - The company's cash and cash equivalents decreased from ¥130,812,145.32 to ¥101,491,421.45, a decline of approximately 22.4%[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,372,487,389.28, a decrease of 0.36% from the end of the previous year[5] - Total assets amounted to ¥1,372,487,389.28, slightly down from ¥1,377,513,566.58 at the end of the previous period[18] - Total liabilities decreased to ¥230,458,755.42 from ¥260,187,910.49, reflecting a reduction of 11.4%[18] - The total current assets decreased from ¥1,067,692,847.33 to ¥1,045,446,572.32, a reduction of about 2.1%[16] Investments and Expenses - Investment income decreased by 53.56% to ¥773,638.42, attributed to reduced returns from financial products[10] - Research and development expenses rose to ¥24,288,848.52, up 18.0% from ¥20,447,053.55, indicating a focus on innovation[19] - The company's financial expenses increased by 424.84% to -¥4,516,116.11, primarily due to increased exchange gains[10] - Cash paid for the purchase of fixed assets and intangible assets is ¥45,047,054.25, down from ¥73,126,935.76 in the previous period[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,262[12] - The largest shareholder, Changzhou Changqing Industrial Investment Group Co., Ltd., holds 30.60% of shares, totaling 42,228,000 shares[12] - The company has a total of 10.23% of shares held by foreign entity, Ewei Holdings Limited, amounting to 14,118,400 shares[12] Inventory and Receivables - Accounts receivable increased from ¥341,277,165.42 to ¥372,794,847.69, representing an increase of about 9.5%[16] - Inventory rose from ¥145,568,239.30 to ¥168,794,589.16, indicating an increase of approximately 15.9%[16] - The company reported a significant increase in contract liabilities by 347.19% to ¥7,861,078.00, mainly due to increased customer prepayments[9] - The company reported a significant increase in contract liabilities, which rose to ¥7,861,078.00 from ¥1,757,875.54, suggesting growth in future revenue streams[19] Impairment and Provisions - The company experienced a 283.73% increase in credit impairment losses, totaling -¥3,845,599.02, due to higher provisions for bad debts[10]

北京铜官盈新文化旅游发展股份有限公司 2025 年第三季度报告 证券代码：000620 证券简称：盈新发展 公告编号：2025-076 北京铜官盈新文化旅游发展股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大 遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 北京铜官盈新文化旅游发展股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 396,3 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 广东宏川智慧物流股份有限公司 2025 年第三季度报告 证券代码:002930 债券代码:128121 证券简称:宏川智慧 债券简称:宏川转债 公告编号:2025-138 广东宏川智慧物流股份有限公司 2025 年第三季度报告 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 0是 ☑否 l 广东宏川智慧物流股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 日是 ☑否 | 项目 | 本报告期 | 本报告期比上年 | 年初至报告 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | 期末 | 比上年同期增减 | | ...

广东冠豪高新技术股份有限公司 2025 年第三季度报告 证券代码：600433 证券简称：冠豪高新 广东冠豪高新技术股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 | 量净额 | | | | | | --- | --- | --- | --- | --- | | 基本每股收益（元/股） | -0.02 | 不适用 | -0.05 | -236.35 | | 稀释每股收益（元/股） | -0.02 | 不适用 | -0.05 | -236.35 | | 加权平均净资产收益率 | -0.80 | 不适用 | -2.08 | 减少 232.30 个 | | （%） | | | | 百分点 | | | 本报告期末 | 上年度末 | | 本报 ...

Revenue and Profitability - Revenue for Q3 2025 was CNY 203,344,161.17, a decrease of 30.00% compared to the same period last year[5] - Net profit attributable to shareholders was a loss of CNY 9,989,150.34, representing a 95.24% increase in loss year-over-year[5] - Operating revenue for the first nine months of 2025 was CNY 515,084,489.56, down 65.79% from CNY 1,505,650,505.72 in the same period last year[9] - The total net profit for the period was -34,238,069.18, representing a 92.10% improvement compared to -433,517,962.52 from the previous period[10] - Operating profit decreased to -31,204,207.01, showing a 91.48% improvement from -366,345,210.29 in the prior period[10] - The total profit for the period was -31,100,117.33, reflecting a 93.06% improvement compared to -448,329,096.65 from the previous period[10] - The company reported a basic earnings per share of -0.02, improving by 93.10% from -0.29 in the previous period[10] Cash Flow and Assets - Cash flow from operating activities showed a net outflow of CNY 46,083,306.98, a decline of 66.42% compared to the beginning of the year[5] - The net cash flow from operating activities was -46,083,306.98, a 66.42% improvement from -137,216,060.16 in the previous year[10] - The cash and cash equivalents net increase was -432,327,472.73, a significant decline of 1169.69% from -34,049,933.44 in the prior period[10] - The company's cash and cash equivalents dropped significantly to ¥148,174,321.30 from ¥542,934,453.45, a decline of about 72.7%[19] - The ending cash and cash equivalents balance is ¥102,216,175.42, down from ¥425,371,068.39 in the previous period[25] Assets and Liabilities - Total assets decreased by 13.41% to CNY 1,222,215,857.29 compared to the end of the previous year[5] - The company's total assets amounted to ¥1,222,215,857.29, a decrease from ¥1,411,518,298.06 at the beginning of the period[20] - The company's current assets decreased to ¥742,849,407.42 from ¥920,463,652.61, indicating a reduction of approximately 19.3%[20] - Total liabilities decreased to ¥1,254,920,383.65 from ¥1,417,962,705.38, a reduction of about 11.5%[21] - The company's total equity attributable to shareholders was a negative CNY 31,897,078.67, a decline of 420.56% due to operational losses[9] - The company's total equity attributable to shareholders decreased to -¥31,897,078.67 from -¥6,127,507.99, indicating a worsening financial position[21] Inventory and Receivables - Accounts receivable increased by 448.80% to CNY 93,364,991.68, primarily due to uncollected project payments[9] - Accounts receivable increased to ¥93,364,991.68 from ¥17,012,541.38, reflecting a growth of approximately 448.5%[19] - Inventory surged by 7503.61% to CNY 19,204,658.38, attributed to increased material purchases[9] - The company reported a significant increase in inventory, rising to ¥19,204,658.38 from ¥252,572.86, marking a growth of approximately 7,487.5%[19] Research and Development - Research and development expenses decreased by 69.76% to CNY 15,293,962.92, mainly due to changes in the consolidation scope[9] - Research and development expenses for the current period are ¥15,293,962.92, a decrease of 69.8% from ¥50,569,614.05 in the previous period[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,219[12] - The largest shareholder, Zhuhai Dahengqin Group Co., Ltd., holds 20.37% of the shares, totaling 308,888,983 shares[12] Regulatory and Corporate Actions - The company received an administrative regulatory measure decision from the Shenzhen Securities Regulatory Bureau on October 17, 2025, emphasizing the importance of compliance and internal management[16] - On October 24, 2025, the company signed a conditional share transfer agreement, with the controlling shareholder transferring 75,964,060 shares (5.01% of total shares) to Hainan Shitong Niu Investment Co., Ltd.[17] - Following the share transfer, Hainan Shitong Niu will hold 499,244,483 shares, representing 25.74% of voting rights, changing the controlling shareholder to Hainan Shitong Niu Investment Co., Ltd.[17] Financial Reporting - The third quarter financial report of Shenzhen Baoying Construction Holdings Group Co., Ltd. has not been audited[26] - The new accounting standards will be implemented starting from 2025[26]

证券代码：002422 证券简称：科伦药业 公告编号：2025-079 四川科伦药业股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 四川科伦药业股份有限公司 2025 年第三季度报告 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 四川科伦药业股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 2 四川科伦药业股份有限公司 2025 年第三季度报告 | 减：所得税影响额 | 6,673,168.00 | 18,855,109.00 | | | --- | --- | --- | --- | | 少数股东权益影响额 （税后） | 8,628,878.00 | 19,831 ...

Financial Performance - The company's operating revenue for Q3 2025 was CNY 2,456.64 million, a slight increase of 0.31% compared to CNY 2,448.29 million in the same period last year[4]. - The total profit for the quarter reached CNY 291.62 million, representing a significant increase of 93.87% year-over-year from CNY 149.80 million[4]. - Net profit attributable to shareholders was CNY 230.04 million, up 81.51% from CNY 126.30 million in the previous year[4]. - Basic earnings per share for the quarter were CNY 0.4582, reflecting an increase of 81.54% compared to CNY 0.2516 in the same period last year[4]. - Total operating revenue for the first three quarters of 2025 reached ¥72,988,485,925.27, a slight increase from ¥72,369,400,917.40 in the same period of 2024, representing a growth of approximately 0.86%[18]. - Net profit for the first three quarters of 2025 was ¥5,734,509,170.16, compared to ¥4,495,891,977.42 in 2024, indicating a year-over-year increase of about 27.6%[19]. - Earnings per share for the first three quarters of 2025 was ¥1.0924, compared to ¥0.8564 in the same period of 2024, reflecting an increase of about 27.5%[20]. - The company reported a total comprehensive income of ¥3.19 billion for the first three quarters of 2025, compared to ¥3.94 billion in the same period of 2024[30]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 22,440.13 million, marking a 7.91% increase from CNY 20,762.33 million at the end of the previous year[4]. - The equity attributable to shareholders increased by 10.09% to CNY 7,431.02 million from CNY 6,743.99 million at the end of the previous year[4]. - As of September 30, 2025, total assets amounted to CNY 224.40 billion, an increase from CNY 207.96 billion as of December 31, 2024, reflecting a growth of approximately 7.0%[13]. - The total liabilities increased to ¥125,960,667,064.09 as of September 30, 2025, up from ¥117,649,879,956.16 at the end of 2024, reflecting a growth of approximately 7.5%[15]. - The total equity attributable to shareholders of the parent company increased to ¥74,310,184,789.59 as of September 30, 2025, from ¥67,496,588,818.14 at the end of 2024, reflecting a growth of approximately 10.5%[15]. Cash Flow - The company reported a net cash flow from operating activities of CNY 611.07 million for the year-to-date, down 17.55% from CNY 744.19 million in the same period last year[4]. - Operating cash inflow for the first three quarters of 2025 reached CNY 87.22 billion, an increase of 10.5% compared to CNY 79.10 billion in the same period of 2024[22]. - Net cash flow from operating activities decreased to CNY 6.11 billion in 2025 from CNY 7.41 billion in 2024, representing a decline of 17.6%[23]. - Cash inflow from investment activities surged to CNY 11.34 billion in 2025, compared to CNY 3.01 billion in 2024, marking an increase of 276.5%[23]. - Cash and cash equivalents at the end of September 2025 amounted to CNY 21.59 billion, up from CNY 18.34 billion at the end of 2024, reflecting a growth of 17.3%[24]. - Cash flow from operating activities generated a net amount of ¥1.25 billion in the first three quarters of 2025, significantly higher than ¥245.43 million in the same period of 2024[33]. Investments and Expenses - Non-recurring gains and losses for the period amounted to CNY 1,237.59 million, primarily driven by fair value changes in financial assets[6]. - The company reported an investment income of ¥323,904,895.99 for the first three quarters of 2025, significantly higher than ¥31,250,124.01 in 2024, indicating a substantial increase[19]. - Research and development expenses for the first three quarters of 2025 were ¥71.72 million, a slight increase from ¥68.95 million in the same period of 2024[29]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 354,115[9]. - The company noted that there were no changes in the top 10 shareholders due to margin trading activities[11].

深圳天德钰科技股份有限公司 2025 年第三季度报告 证券代码：688252 证券简称：天德钰 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 | 年初至报告期末 | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 489,894,001.44 | -23.58 | 1,698,045,913.19 | 14.44 | | 利润总额 | 46,014,241.62 | -52.66 | 210,542,578.63 | 3.12 | | 归属于上市公司股东的 净 ...

山东晨鸣纸业集团股份有限公司 2025 年第三季度报告 证券代码：000488 200488 证券简称：ST 晨鸣 ST 晨鸣 B 公告编号：2025-072 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1、董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 山东晨鸣纸业集团股份有限公司 □是 ☑否 1 山东晨鸣纸业集团股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 3、第三季度报告是否经过审计 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 期增减 | | 比上年同期增减 | | 营业收入（元） | 1,241,229, ...